Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress

Posted: Updated:

SAN FRANCISCO, CA / March 31, 2014 / Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his blog, Mr. Commissiong outlines Amarantus’ recent achievement of key milestones that the company believes will add significant value in the commercialization and development of the LymPro test (R) for Alzheimer’s. “As we prepare for LymPro’s commercialization in the second half of 2014, we believe it is critical to properly position LymPro within the scientific community, the investment community and the general population as THE commercially-validated blood test as we prepare for product launch,” states Mr. Commissiong. Read the full blog post from Mr. Gerald Commissiong on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/commercialization-track-2014-updating-lympro-test-progress/).

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test®”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

 

SOURCE: Amarantus Bioscience Holdings, Inc.

ReleaseID: 413716

  • Today's Top StoriesMore>>

  • President Obama Expected to Make Statement on Beheaded Journalist

    President Obama Expected to Make Statement on Beheaded Journalist

    Wednesday, August 20 2014 12:37 PM EDT2014-08-20 16:37:15 GMT
    President Barack Obama is expected to make a statement today about the beheading of American journalist James Foley by militants with the Islamic State extremist group.More >>
    President Barack Obama is expected to make a statement today about the beheading of American journalist James Foley by militants with the Islamic State extremist group.More >>
  • Burning Man Boosts RV Rental Business

    Burning Man Boosts RV Rental Business

    Wednesday, August 20 2014 12:36 PM EDT2014-08-20 16:36:43 GMT
    We are days away from Burning Man, the counter-culture festival that takes place every August in the Black Rock Desert. But when people head to the playa, they need a place to stay. That is good news for companies who rent RVs.More >>
    We are days away from Burning Man, the counter-culture festival that takes place every August in the Black Rock Desert. But when people head to the playa, they need a place to stay. That is good news for companies who rent RVs.More >>
  • Nevada's ACT Test Takers Score Above U.S. Average

    Nevada's ACT Test Takers Score Above U.S. Average

    Wednesday, August 20 2014 12:31 PM EDT2014-08-20 16:31:06 GMT
    Makers of the ACT test say Nevada's Class of 2014 scored higher than the national average in English, reading and math, although only about one-third of graduates took the exam.More >>
    Makers of the ACT test say Nevada's Class of 2014 scored higher than the national average in English, reading and math, although only about one-third of graduates took the exam.More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.